Table 1.
Baseline characteristics of hospitalized patients with advanced chronic liver disease (ACLD), N = 168*
| Median (interquartile range) or n (%) | |
|---|---|
|
Age, years |
57.9 (14.3) |
|
Men (%) |
109 (64.9) |
|
Body mass index, kg/m2 |
26.0 (5.9) |
|
Etiology of ACLD |
|
|
alcohol |
132 (78.6) |
|
NASH |
20 (11.9) |
|
viral |
9 (5.4) |
|
AI |
8 (4.8) |
|
other |
11 (6.5) |
|
>1 factor |
12 (7.1) |
|
Hepatocellular carcinoma (%) |
3 (1.8) |
|
Serum albumin, g/L |
28 (8) |
|
Serum sodium, mmol/L |
135 (6) |
|
C reactive protein, mg/L |
12.5 (19.2) |
|
Child Pugh Turcotte score |
9.00 (3) |
|
MELD-Na score |
16.00 (9) |
|
MELD-Na ≥20 points (%) |
46 (27.4) |
|
Infection on admission (%) |
54 (32.1) |
|
Number connection test, s† |
67 (65) |
|
Hepatic encephalopathy stage grade |
|
|
0 |
121 (72) |
|
1 |
29 (17.3) |
|
2 |
17 (10.1) |
|
3-4 |
1 (0.6) |
|
Ascites grade |
|
|
none |
53 (31.5) |
|
controlled |
54 (32.1) |
|
refractory |
61 (36.3) |
|
In hospital days |
6 (8.25) |
|
Follow-up event and duration, n (%), days |
|
|
none |
104 (61.9), 300.5 |
|
liver transplantation |
10 (6.0), 117.5 |
|
death |
54 (32.1), 35.5 |
|
Mortality |
|
|
in hospital |
15 (9) |
|
30 days |
24 (14.3) |
|
90 days |
41 (24.4) |
| 180 days | 51 (30.4) |
*Abbreviations: AI – cirrhosis due to autoimmune disease; NASH – cirrhosis due to non-alcoholic steatohepatitis; MELD- Na – Model for End-Stage Liver Disease-Sodium Score.
†N = 157.